DNA sequencing may help predict a patient's risk of kidney cancer recurrence

Studying the mutations in kidney cancer after surgery could help to better predict the risk of the disease coming back, according to the latest results of a decade-long international study.

Related Keywords

United States ,Canada ,Naveen Vasudev ,Emily Henderson ,Yasser Riazalhosseini ,Victor Phillip Dahdaleh Institute Of Genomic Medicine ,Cancer Research ,Cancer Research Industry ,Leeds Institute Of Medical Research ,University Of Leeds ,Mcgill University ,Assistant Professor ,Human Genetics ,Cancer Genomics ,Victor Phillip Dahdaleh Institute ,Genomic Medicine ,Research Industry Focus ,Associate Professor ,Honorary Consultant ,Medical Oncology ,Leeds Institute ,Cancer ,Genes ,Kidney ,Kidney Cancer ,Na ,Na Sequencing ,Enetic ,Enetics ,Enomic ,Genomics ,Medical Research ,Medicine ,Utation ,Ncology ,Research ,Surgery ,Humor ,